Slow down age related macular degeneration using your genetics
EyeGen can help build your blue print for better eye health
Understand your Risk. Protect your family
AMD is considered one of the most powerfully genetic-dominant diseases discovered to date. Your genetic profile can account for over 60% of the risk of developing AMD. Having a first-degree relative (mother, father, brother, sister) with AMD significantly increases. Protect yourself, protect your family.
Real Stories from AMD patients:
“While searching for a macular degeneration treatment, I took the EyeGen test and found that I had 2 copies of the CFH risk markers and no risk copies of the ARMS2 gene. My eyecare provider immediately put me on a different supplement matching my genotype.”
A different way to think about AREDs
Know your genetics. Establish your personalized treatment plan.
Your genetic profile accounts for 60% of the cause of AMD while the rest is attributed to individual and environmental factors. Many patients with AMD are taking AREDs formulations. However, 15% of patients taking this supplement are actually increasing progression. The EyeGen test will reveal whether you are harmed or helped by an AREDs formulation and recommend a supplement that is personalized based on your genetics.
Our lab is certified according to the College of American Pathology (CAP), the Clinical Laboratory Improvement Amendments (CLIA) and the Clinical Laboratory Evaluation Program (CLEP).
Newest 2023 Research
A recent study published in March 2023 in the Journal of Clinical Medicine, analysed the effects of macular degeneration to: age, sex, and visual acuity. The study revealed that a genetic variant associated with CFH may cause AMD advancement over a 3-year period. This finding confirmed data from the newest meta-analyses based on pooled studies, including 17,174 individuals 45 years of age or older participating in 6 population-based cohort studies, 2 clinic-based studies and 1 case‒control study, demonstrating that CFH gene is the leading driver of late forms of AMD. 60 and 61
Krytkowska, E.; Ulańczyk, Z.; Grabowicz, A.; Safranow, K.; Kawa, M.P.; Pałucha, A.; Wąsowska, A.; Matczyńska, E.; Boguszewska-Chachulska, A.; Machalińska, A. Influence of Clinical and Genetic Factors on the Progression of Age-Related Macular Degeneration: A 3-Year Follow-Up. J. Clin. Med. 2023, 12, 1963.
60. Bonyadi, M.H.J.; Yaseri, M.; Nikkhah, H.; Bonyadi, M.; Nazari, R.; Soheilian, M. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: A meta-analysis. Int. Ophthalmol. 2018, 39, 949–956.
61. Colijn, J.M.; Meester-Smoor, M.; Verzijden, T.; de Breuk, A.; Silva, R.; Merle, B.M.; Cougnard-Grégoire, A.; Hoyng, C.B.; Fauser, S.; Coolen, A.; et al. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium. Ophthalmology 2020, 128, 1039–1049.
The results from your DNA swab:
Introductory offer! Complimentary 6 months supply of personalized nutritional supplements based on your genotype + 10 minute telehealth consultation ($180 value)
Macular Degeneration Genetic Testing In The Media
Learn how AMD genetic testing is being integrated into eyecare while helping in-patient treatment
Macular degeneration runs in families. Know your genetic risk.
Protect yourself. Protect your family.
Receive a volume discount when you purchase more than 1 kit.
How it works
Order your kit online.
Swab Your Cheeks
Follow instructions on swabbing.
Mail Back EyeGen
Mail the kit back to us with free postage. We’ll get it analyzed.
We’ll send you a code via email to check your results.
Patients that EyeGen have helped so far...
EyeGen has helped thousands of patients identify their genetic risk for Age Related Macular Degeneration and determine which supplement will provide the greatest protection
What is Age Related Macular Degeneration (AMD)?
AMD is a progressive eye disease affecting the clear central vision needed for daily activities like reading or driving, leaving only peripheral vision intact. As toxic drusen deposits build up in the macula, cells responsible for vision begin to break down under oxidative attack, leading to poor visual function. One in five AMD cases will progress to the advance forms of the disease.
Risk Factors For Macula Degeneration
A diagnosis of AMD can be scary
Fortunately, AMD is generally a slow moving condition, and most people have an early dry forms of the disease. This buys time to make positive lifestyle changes such as improving diet, exercise habits, and adding ocular nutrition products to help maintain eyesight.
Everything you need to know about EyeGen Genetic Test
Multiple genetic research studies reveal that zinc-based eye vitamins like AREDS/AREDS2 used to prevent the progression of age-related macular degeneration (AMD) are not safe for 15% of patients. For AMD patients with a specific genotype, the risk of developing wet AMD is tripled by taking supplemental zinc formulations (25 mg per day and higher), which increases the risk of vision loss. Only an EyeGen test can identify those who have an increased risk of progression to wet AMD after exposure to zinc. This helps those with dry AMD avoid supplements that increase their risk of vision loss. The EyeGen test also identifies those who are high risk for AMD progression. These individuals would then require increased surveillance and early referral to a specialist to help preserve their sight.